monkeybusinessimages/iStock via Getty Images AbCellera Biologics (ABCL) is up ~35% in Monday morning trading after announcing top-line phase 2 data for ABCL635, its candidate for moderate-to-severe vasomotor symptoms (hot flashes)…
Results
-
-
Investment
ParkwayLife Reit – Tuesday, 4th August whe is going to released her 1st Half results. Estimating DPU of 8.5 to 8.7 cents. The results will be out before trading commence
ParkwayLife Reit – Tuesday, 4th August whe is going to released her 1st Half results. Estimating DPU of 8.5 to 8.7 cents. The results will be out before trading commence.…
-
Investment
Data Center Stock Digital Realty (NYSE: DLR) Makes NYSE Top Gainer List on Second Quarter Results
Shares jumped over 14% after the data center REIT posted record Core FFO per share and raised its full-year outlook. Investorideas.com (www.investorideas.com) a trusted platform for investing ideas including AI…
-
Investment
Tvardi Therapeutics (Nasdaq: TVRD) Soars on Positive Phase 1 Results for Next-Gen STAT3 Inhibitor TTI-109
Tvardi’s next-generation STAT3 inhibitor TTI-109 confirmed rapid prodrug conversion, dose-proportional exposure, and improved tolerability versus TTI-101 in Phase 1 testing. Investorideas.com (www.investorideas.com) a trusted platform for investing ideas, including biotech…
-
Published on May 20, 2026 Share JOIN OUR FREE TELEGRAM SERVER TODAY Real-time stock alerts across Mining, Crypto, AI/Tech, Defense &…
-
Investment
United Hampshire US REIT Amazing Q1 2026 Results- Distribution Yield Now Around 9% Per Annum.
United Hampshire US REIT (“UHREIT”) reported a strong 1Q 2026, with distributable income rising 10.0% year-on-year to US$6.9 million, driven by higher rents, active leasing and contributions from two newly…
-
AngloGold Ashanti press release (AU): Q1 Non-GAAP EPS of $2.52 beats by $0.28. Revenue of $3.15B (+63.2% Y/Y) misses by $120M. Free cash flow, the strongest for a single quarter,…
-
A polished real estate agent brand does not start with trendy scripts, overproduced reels or bloated newsletters. It starts with something simpler and harder to fake: authenticity. That is the…
-
Investment
Biotech Stock Edesa Biotech (Nasdaq:EDSA) Gains on News of Additional Positive Results from Phase 3 Paridiprubart Study
Published on Feb 24, 2026 Share (Investorideas.com Newswire) a go-to platform for big investing ideas, including biotech…
-
Keppel DC REIT, Singapore’s first pure‑play data centre REIT, continues to strengthen its position as a leading digital infrastructure landlord with assets across Asia Pacific and Europe. The REIT released…
